Investing.com - Deciphera Pharma (NASDAQ: DCPH) reported first quarter EPS of $-0.54, better than the analyst estimate of $-0.55. Revenue for the quarter came in at $46.7M versus the consensus estimate of $46.28M.
Deciphera Pharma's stock price closed at $25.36. It is up 75.14% in the last 3 months and up 82.05% in the last 12 months.
Deciphera Pharma saw 6 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Deciphera Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Deciphera Pharma's Financial Health score is "good performance".
Check out Deciphera Pharma's recent earnings performance, and Deciphera Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar